文献速递心血管乳腺MR

乳腺癌放疗后2年内心脏MRI评估的亚临床心功能障碍:MEDIRAD EARLY-HEART研究

Cardiac MRI-based Subclinical Cardiac Dysfunction during 2 Years after Breast Cancer Irradiation: The MEDIRAD EARLY-HEART Study.
PubMed 文献 · Radiol Cardiothorac Imaging · 2025-01-01

前瞻性多中心研究纳入138例保乳术后仅接受放疗的乳腺癌女性,于基线、6个月和24个月行心脏MRI。全心脏和左心室平均剂量分别为1.42 Gy和1.46 Gy。随访2年时23例(16.6%)出现左心室整体纵向应变持续降低,其全心脏和左心室剂量均高于无持续降低者;较高的全心脏剂量与左心室整体纵向应变持续降低风险相关(OR 1.09)。

要点

  • 全心脏剂量较高与左心室整体纵向应变持续降低风险相关(OR 1.09)。
  • 出现应变持续降低者全心脏剂量2.09 Gy vs 无降低者1.36 Gy(P < .001)。
  • 2年随访所有受试者左心室舒张末期容积和每搏输出量降低、左心室重构指数升高。

核心结论

  • 在接受近期乳腺癌放疗的参与者中,2年随访期间左心室整体纵向应变出现适度但持续的降低,且与心脏放疗剂量相关。

研究设计与样本

  • 前瞻性多中心研究(NCT03297346),2017年12月至2019年9月纳入138例保乳术后接受放疗、未化疗的女性乳腺癌患者,于基线、6个月和24个月行心脏MRI,评估全心脏及左右心室放疗剂量。

关键影像表现/征象

  • 2年随访时所有参与者左心室舒张末期容积降低(-4.0% ± 13.2,P < .001)、每搏输出量降低(-3.4% ± 15.2,P < .001)。
  • 2年随访时所有参与者左心室射血分数保留、左心室重构指数(左心室质量/舒张末期容积比值)升高(4.2% ± 18.1,P < .04),无相关症状。
  • 出现左心室整体纵向应变持续降低者相对无持续降低者,左心室舒张末期容积相对变化为-12.7% ± 9.0 vs -2.2% ± 13.3(P < .001)。
  • 出现左心室整体纵向应变持续降低者相对无持续降低者,左心室质量/舒张末期容积相对变化为14.2% ± 15.5 vs 2.2% ± 18.1(P = .002)。

诊断标准与关键数值

  • 左心室整体纵向应变自基线至2年随访两个测量点持续降低定义为心脏功能不良亚临床改变。
  • 全心脏剂量较高与左心室整体纵向应变持续降低风险较高相关(OR 1.09,95% CI:1.02,1.16)。
  • 左心室整体纵向应变持续降低者全心脏平均剂量2.09 Gy(IQR,1.50-2.45)vs 无持续降低者1.36 Gy(IQR,1.01-1.87),P < .001。
  • 左心室整体纵向应变持续降低者左心室平均剂量2.40 Gy(IQR,1.09-2.88)vs 无持续降低者1.34 Gy(IQR,0.63-2.02),P = .002。

临床应用与阅片要点

  • 对乳腺癌放疗后患者行心脏MRI随访时,可关注左心室整体纵向应变较基线的持续变化。
  • 全心脏和左心室放疗剂量较高者,左心室整体纵向应变持续降低的风险似乎更高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To evaluate the relationship between cardiac radiation doses and subclinical changes in cardiac function using cardiac MRI during 2 years of follow-up in patients with breast cancer treated with radiation therapy without chemotherapy after lumpectomy. Materials and Methods This prospective multicenter study (NCT03297346) enrolled female individuals with breast cancer treated with radiation therapy between December 2017 and September 2019. Participants underwent cardiac MRI at baseline, 6 months, and 24 months. Cardiac radiation doses were assessed for the whole heart (WH) and right and left ventricles (LV). A persistent decrease in LV global longitudinal strain (GLS) from baseline to the other two measurement points over the 2-year follow-up was considered an adverse subclinical change in cardiac function. Statistical analysis included Wilcoxon tests for continuous variables and odds ratios for risk assessment. Results The study included 138 female participants (mean age, 58.4 years ± 8.0 [SD]). Mean WH and LV doses were 1.42 Gy (IQR, 1.03-2.01) and 1.46 Gy (IQR, 0.64-2.34). At the 2-year follow-up, all participants had reduced LV end-diastolic volume (EDV) (-4.0% ± 13.2; P < .001) and stroke volume (-3.4% ± 15.2; P < .001), preserved LV ejection fraction, and increased LV remodeling (LV mass/EDV ratio) (4.2% ± 18.1; P < .04) without associated symptoms. Twenty-three (16.6%) participants showed a persistent decrease in LV GLS and received higher mean WH and LV doses compared with participants without persistent decrease in LV GLS (WH: 2.09 Gy [IQR, 1.50-2.45] vs 1.36 Gy [IQR, 1.01-1.87], P < .001; LV: 2.40 Gy [IQR, 1.09-2.88] vs 1.34 Gy [IQR, 0.63-2.02], P = .002). The relative changes in LV EDV and LV mass/EDV were -12.7% ± 9.0 versus -2.2% ± 13.3 (P < .001) and 14.2% ± 15.5 versus 2.2% ± 18.1 (P = .002), respectively, in participants with and without a persistent decrease in LV GLS. A higher WH cardiac radiation dose was associated with a higher risk of a persistent decrease in LV GLS (odds ratio, 1.09 [95% CI: 1.02, 1.16]). Conclusion In participants with recent breast cancer radiation therapy, a modest but persistent reduction in LV GLS over a 2-year follow-up period was associated with the cardiac radiation dose. Keywords: Radiotherapy, Magnetic Resonance Imaging, Cardiotoxicity, Strain Clinical trial registration no. NCT03297346 Supplemental material is available for this article. © RSNA, 2025.

来源:Radiol Cardiothorac Imaging,查看原文。版权归原作者所有。

引用

  1. Lamy J, Spoor DS, Langendijk JA, et al. Cardiac MRI-based Subclinical Cardiac Dysfunction during 2 Years after Breast Cancer Irradiation: The MEDIRAD EARLY-HEART Study. Radiol Cardiothorac Imaging. 2025. PMID: 40178396. doi:10.1148/ryct.240231

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。